Budget Amount *help |
¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2011: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2010: ¥2,340,000 (Direct Cost: ¥1,800,000、Indirect Cost: ¥540,000)
|
Research Abstract |
Gimeracil is a component of TS-1, an anti-cancer drug. Gimeracil enhanced cell-killing effects of camptothecin(CPT), 5-Fluorouracil(5-FU), and hydroxyurea. Combination of Gimeracil and CPT or 5-FU sensitized radiation more effectively than each modality alone. Gimeracil also enhanced heat sensitivity at 42℃or more. Combination of Gimeracil and heat sensitized radiation more than each modality alone did.
|